as on February 13, 2026 at 9:31 pm IST
Day's Low
Day's High
0.69%
Downside
2.68%
Upside
52 Week's Low
52 Week's High
10.27%
Downside
38.02%
Upside
as on February 13, 2026 at 4:01 pm IST
Market Cap
₹7,103.98 Cr
Return on Equity (ROE)
13.15
PE Ratio (TTM)
21.72
Return on capital employed (ROCE)
10.7
Industry PE ratio
41.52
Beta (LTM)
1.19
P/B Ratio
3.15
Dividend Yield
0PEG Ratio
2.01
Quarterly Earnings Growth YOY
2.05
EPS (TTM)
22.45
Sector
Pharmaceuticals
Book Value
199.01
Technical Analysis
Neutral
View Technical Analysis
as on February 13, 2026 at 4:01 pm IST
Akums Drugs in the last 5 years
Lowest (18.75x)
April 7, 2025
Today (21.72x)
February 13, 2026
Industry (41.52x)
February 13, 2026
Highest (66.86x)
August 19, 2024
Today’s Price to Earnings Ratio: 21.72x
Compare market cap, revenue, PE, and other key metrics of Akums Drugs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 7,103.98 | -8.66% | 0.53 | 343 | 4,118 | |
| BUY | 13,159.14 | 52.75% | 0.51 | 541 | 1,937 | |
| BUY | 29,339.82 | -3.57% | 0.53 | 698 | 5,616 | |
| NA | 2,112.36 | 5.92% | 0.57 | 118 | 1,811 | |
| NA | 120.57 | -16.38% | 0.59 | 25 | 292 |
Based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Akums Drugs. Average target price of ₹610
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Akums Drugs.
What analysts predicted
35.15%UPSIDE
Target Price
₹610
Current Price
₹451.35
Analyzed by
3 Analysts
High
₹740
Target
₹610.00
Low
₹600
Akums Drugs target price ₹610, a slight upside of 35.15% compared to current price of ₹451.35. According to 3 analysts rating.
Source: S&P Global Market Intelligence
Search interest for Akums Drugs & Pharmaceuticals Ltd Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Akums Drugs.
Akums Drugs & Pharmaceuticals Ltd’s net profit jumped 1.75% since last year same period to ₹66.32Cr in the Q3 2025-2026. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated 62.63% jump in its net profits since last 3-months.
Read More about Earnings ResultsCheck stock indices that include Akums Drugs.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
![]()
Mutual Funds have increased holdings from 6.44% to 11.23% in Dec 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 75.26% of holdings in Dec 2025 quarter
Price Dip
![]()
In the last 7 days, AKUMS stock has moved down by -3.4%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 2.28% to 1.15% in Dec 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 10.46% to 6.46% in Dec 2025 quarter
| Organisation | Akums Drugs & Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Akums Drugs share price today stands at ₹451.35 as on at the close of the market. Akums Drugs share today touched a day high of ₹463.45 and a low of ₹448.25.
Akums Drugs touched a 52 week high of ₹622.95 and a 52 week low of ₹405. Akums Drugs share price today i.e. is closed at ₹451.35, which is -27.55% down from its 52 week high and 11.44% up from its 52 week low.
Akums Drugs market capitalisation is ₹7,103.98 Cr as on .
To buy Akums Drugs shares, you need to follow these steps:
Akums Drugs trading volume is 70.72K as on . This means that 70.72K shares of Akums Drugs were bought and sold on the stock market during today's trading session.